
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The SysteMHC Atlas project
Wenguang Shao, Patrick G. A. Pedrioli, Witold Wolski, et al.
Nucleic Acids Research (2017) Vol. 46, Iss. D1, pp. D1237-D1247
Open Access | Times Cited: 140
Wenguang Shao, Patrick G. A. Pedrioli, Witold Wolski, et al.
Nucleic Acids Research (2017) Vol. 46, Iss. D1, pp. D1237-D1247
Open Access | Times Cited: 140
Showing 1-25 of 140 citing articles:
The ProteomeXchange consortium in 2020: enabling ‘big data’ approaches in proteomics
Eric W. Deutsch, Nuno Bandeira, Vagisha Sharma, et al.
Nucleic Acids Research (2019)
Open Access | Times Cited: 702
Eric W. Deutsch, Nuno Bandeira, Vagisha Sharma, et al.
Nucleic Acids Research (2019)
Open Access | Times Cited: 702
Noncoding regions are the main source of targetable tumor-specific antigens
Céline M. Laumont, Krystel Vincent, Leslie Hesnard, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 470
Open Access | Times Cited: 443
Céline M. Laumont, Krystel Vincent, Leslie Hesnard, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 470
Open Access | Times Cited: 443
The ProteomeXchange consortium at 10 years: 2023 update
Eric W. Deutsch, Nuno Bandeira, Yasset Pérez‐Riverol, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1539-D1548
Open Access | Times Cited: 439
Eric W. Deutsch, Nuno Bandeira, Yasset Pérez‐Riverol, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1539-D1548
Open Access | Times Cited: 439
MHCflurry: Open-Source Class I MHC Binding Affinity Prediction
Timothy O’Donnell, Alex Rubinsteyn, Maria Bonsack, et al.
Cell Systems (2018) Vol. 7, Iss. 1, pp. 129-132.e4
Open Access | Times Cited: 365
Timothy O’Donnell, Alex Rubinsteyn, Maria Bonsack, et al.
Cell Systems (2018) Vol. 7, Iss. 1, pp. 129-132.e4
Open Access | Times Cited: 365
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Anthony W. Purcell, Sri H. Ramarathinam, Nicola Ternette
Nature Protocols (2019) Vol. 14, Iss. 6, pp. 1687-1707
Closed Access | Times Cited: 292
Anthony W. Purcell, Sri H. Ramarathinam, Nicola Ternette
Nature Protocols (2019) Vol. 14, Iss. 6, pp. 1687-1707
Closed Access | Times Cited: 292
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing
Timothy O’Donnell, Alex Rubinsteyn, Uri Laserson
Cell Systems (2020) Vol. 11, Iss. 1, pp. 42-48.e7
Open Access | Times Cited: 283
Timothy O’Donnell, Alex Rubinsteyn, Uri Laserson
Cell Systems (2020) Vol. 11, Iss. 1, pp. 42-48.e7
Open Access | Times Cited: 283
Predicting HLA class II antigen presentation through integrated deep learning
Binbin Chen, Michael S. Khodadoust, Niclas Olsson, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 11, pp. 1332-1343
Open Access | Times Cited: 262
Binbin Chen, Michael S. Khodadoust, Niclas Olsson, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 11, pp. 1332-1343
Open Access | Times Cited: 262
The emerging role of mass spectrometry-based proteomics in drug discovery
Felix Meissner, Jennifer Geddes‐McAlister, Matthias Mann, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 637-654
Closed Access | Times Cited: 224
Felix Meissner, Jennifer Geddes‐McAlister, Matthias Mann, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 637-654
Closed Access | Times Cited: 224
T Cell Epitope Predictions
Bjoern Peters, Morten Nielsen, Alessandro Sette
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 123-145
Open Access | Times Cited: 212
Bjoern Peters, Morten Nielsen, Alessandro Sette
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 123-145
Open Access | Times Cited: 212
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Ana Marcu, Leon Bichmann, Lèon Kuchenbecker, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002071-e002071
Open Access | Times Cited: 174
Ana Marcu, Leon Bichmann, Lèon Kuchenbecker, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002071-e002071
Open Access | Times Cited: 174
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Sebastian P. Haen, Markus Löffler, Hans‐Georg Rammensee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 595-610
Open Access | Times Cited: 167
Sebastian P. Haen, Markus Löffler, Hans‐Georg Rammensee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 595-610
Open Access | Times Cited: 167
Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics
Mathias Wilhelm, Daniel P. Zolg, Michael Graber, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 149
Mathias Wilhelm, Daniel P. Zolg, Michael Graber, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 149
Next-generation computational tools for interrogating cancer immunity
Francesca Finotello, Dietmar Rieder, Hubert Hackl, et al.
Nature Reviews Genetics (2019) Vol. 20, Iss. 12, pp. 724-746
Closed Access | Times Cited: 145
Francesca Finotello, Dietmar Rieder, Hubert Hackl, et al.
Nature Reviews Genetics (2019) Vol. 20, Iss. 12, pp. 724-746
Closed Access | Times Cited: 145
Targeting public neoantigens for cancer immunotherapy
Alexander H. Pearlman, Michael S. Hwang, Maximilian F. Konig, et al.
Nature Cancer (2021) Vol. 2, Iss. 5, pp. 487-497
Open Access | Times Cited: 127
Alexander H. Pearlman, Michael S. Hwang, Maximilian F. Konig, et al.
Nature Cancer (2021) Vol. 2, Iss. 5, pp. 487-497
Open Access | Times Cited: 127
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 103
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 103
Malaria prevention: from immunological concepts to effective vaccines and protective antibodies
Ian A. Cockburn, Robert A. Seder
Nature Immunology (2018) Vol. 19, Iss. 11, pp. 1199-1211
Open Access | Times Cited: 154
Ian A. Cockburn, Robert A. Seder
Nature Immunology (2018) Vol. 19, Iss. 11, pp. 1199-1211
Open Access | Times Cited: 154
Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
David Gfeller, Michal Bassani‐Sternberg
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 152
David Gfeller, Michal Bassani‐Sternberg
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 152
Deep Learning in Proteomics
Bo Wen, Wen‐Feng Zeng, Yuxing Liao, et al.
PROTEOMICS (2020) Vol. 20, Iss. 21-22
Open Access | Times Cited: 127
Bo Wen, Wen‐Feng Zeng, Yuxing Liao, et al.
PROTEOMICS (2020) Vol. 20, Iss. 21-22
Open Access | Times Cited: 127
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus Löffler, Christopher Mohr, Leon Bichmann, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 119
Markus Löffler, Christopher Mohr, Leon Bichmann, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 119
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
Lena Katharina Freudenmann, Ana Marcu, Stefan Stevanović
Immunology (2018) Vol. 154, Iss. 3, pp. 331-345
Open Access | Times Cited: 104
Lena Katharina Freudenmann, Ana Marcu, Stefan Stevanović
Immunology (2018) Vol. 154, Iss. 3, pp. 331-345
Open Access | Times Cited: 104
RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, et al.
Nature (2021) Vol. 599, Iss. 7885, pp. 477-484
Open Access | Times Cited: 94
Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, et al.
Nature (2021) Vol. 599, Iss. 7885, pp. 477-484
Open Access | Times Cited: 94
The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases
Juan Antonio Vizcaíno, Peter Kubiniok, Kevin A. Kovalchik, et al.
Molecular & Cellular Proteomics (2019) Vol. 19, Iss. 1, pp. 31-49
Open Access | Times Cited: 90
Juan Antonio Vizcaíno, Peter Kubiniok, Kevin A. Kovalchik, et al.
Molecular & Cellular Proteomics (2019) Vol. 19, Iss. 1, pp. 31-49
Open Access | Times Cited: 90
Beneficial autoimmunity improves cancer prognosis
Laurence Zitvogel, Claude Perreault, Olivera J. Finn, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 591-602
Open Access | Times Cited: 80
Laurence Zitvogel, Claude Perreault, Olivera J. Finn, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 591-602
Open Access | Times Cited: 80
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes
Grégory Ehx, Jean‐David Larouche, Chantal Durette, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 737-752.e10
Open Access | Times Cited: 79
Grégory Ehx, Jean‐David Larouche, Chantal Durette, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 737-752.e10
Open Access | Times Cited: 79
Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction
HuiSong Pak, Justine Michaux, Florian Huber, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100080-100080
Open Access | Times Cited: 70
HuiSong Pak, Justine Michaux, Florian Huber, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100080-100080
Open Access | Times Cited: 70